Lung Cancer Clinical Trial

Nashville Early Diagnosis Lung Cancer Project

Summary

This screening study will address the lack of molecular strategies for the early detection of lung cancer and integrate those with epidemiological and imaging strategies.

The hypothesis is that the repeated measure of biomarkers of risk obtained from the molecular analysis of biological specimens including those from bronchoscopy (bronchial brushings and biopsies) may contribute to the refinement of high-risk populations and allow an earlier clinical diagnosis.

The goal of the investigators study is to provide screening for lung cancer in a high-risk population. In this prospective cohort it will be tested whether repeated measure of biomarkers of risk allows early detection of lung cancer.

View Full Description

Full Description

It is proposed to test the hypotheses in a screening study of high risk individuals (characterized by an established prediction rule). The expected prevalence of lung cancer in this high risk group is estimated to be 2% per year. All individuals benefit from clinic visit, low-dose Chest CT, spirometry and auto-fluorescence bronchoscopy at baseline, Chest CT, follow-up doctor visit, and auto-fluorescence bronchoscopy at least at year 2 and 5.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

55 - 80 years of age
Current smoker or former smoker. If former smoker, must have quit smoking less than 15 years ago
>/= 30 pack year of smoking history

Exclusion Criteria:

History of diagnosis/treatment of lung cancer in the past 2 years
History of head/neck or esophageal cancer in the last 1 year
Inability to provide informed consent
Participants in whom stopping anti-platelet or anti-coagulation therapy would have an adverse effect (DVT, mechanical heart valves, unstable coronary syndrome, etc.)

Study is for people with:

Lung Cancer

Estimated Enrollment:

480

Study ID:

NCT01475500

Recruitment Status:

Active, not recruiting

Sponsor:

Vanderbilt-Ingram Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Veterans Administration
Nashville Tennessee, 37212, United States
Vanderbilt University, Vanderbilt-Ingram Cancer Center
Nashville Tennessee, 37232, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

480

Study ID:

NCT01475500

Recruitment Status:

Active, not recruiting

Sponsor:


Vanderbilt-Ingram Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.